Safingol
- Generic Name
- Safingol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H39NO2
- CAS Number
- 15639-50-6
- Unique Ingredient Identifier
- OWA98U788S
- Background
Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
- Associated Conditions
- -
- Associated Therapies
- -
Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT00084812
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath